NeuroPace wins FDA approval for AI tool that reviews brain recordings from its epilepsy implant
ECoG Assistant flags important intracranial EEG recordings from the RNS System, built on more than 124,000 expert-labeled records.
NeuroPace has received FDA approval for ECoG Assistant, an artificial-intelligence tool that helps doctors review the brain recordings collected by its RNS System, an implanted device that detects and responds to epileptic seizures.
What it does
The RNS System records brain activity directly from the brain’s surface (ECoG) for years at a time, which creates far more data than a doctor can read. ECoG Assistant highlights the recordings most likely to matter, which the company calls “ECoGs of Interest”. It also shows trends over months and daily (circadian) patterns.
NeuroPace says the AI was developed using 124,450 intracranial EEG records labeled by epilepsy specialists, drawn from what it calls the world’s only long-term dataset of this kind. It is the first in a planned set of AI features.
Why it matters
Implanted closed-loop devices produce continuous streams of neural data. Tools that turn those streams into usable clinical information are becoming as important as the hardware itself. The approval also shows the FDA is prepared to clear AI software that sits on top of brain implants.
Learn more: Closed-loop systems · Neural decoding · NeuroPace in the Directory